CAPR logo

Capricor Therapeutics (CAPR) Company Overview

Profile

Full Name:

Capricor Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 13, 2007

Indexes:

Not included

Description:

Capricor Therapeutics is a biotechnology company focused on developing innovative therapies for heart disease and other serious conditions. They specialize in regenerative medicine, particularly using stem cell technology to create treatments that promote healing and improve patient outcomes. Their goal is to advance healthcare through scientific innovation.

Key Details

Price

$15.98

Annual Revenue

$25.18 M(+886.80% YoY)

Annual EPS

-$0.83(+29.66% YoY)

Annual ROE

-129.63%

Beta

1.33

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 5, 2019

Analyst ratings

Recent major analysts updates

Jan 2, 25 HC Wainwright & Co.
Buy
Nov 18, 24 Jones Trading
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Cantor Fitzgerald
Overweight
Jul 2, 24 HC Wainwright & Co.
Buy
May 17, 24 Oppenheimer
Outperform
May 14, 24 Ladenburg Thalmann
Buy
May 14, 24 HC Wainwright & Co.
Buy
May 14, 24 Cantor Fitzgerald
Overweight
Apr 25, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Capricor Therapeutics?
  • Does Capricor Therapeutics pay dividends?
  • What sector is Capricor Therapeutics in?
  • What industry is Capricor Therapeutics in?
  • What country is Capricor Therapeutics based in?
  • When did Capricor Therapeutics go public?
  • Is Capricor Therapeutics in the S&P 500?
  • Is Capricor Therapeutics in the NASDAQ 100?
  • Is Capricor Therapeutics in the Dow Jones?
  • When was Capricor Therapeutics's last earnings report?
  • When does Capricor Therapeutics report earnings?
  • Should I buy Capricor Therapeutics stock now?

What is the ticker symbol for Capricor Therapeutics?

The ticker symbol for Capricor Therapeutics is NASDAQ:CAPR

Does Capricor Therapeutics pay dividends?

No, Capricor Therapeutics does not pay dividends

What sector is Capricor Therapeutics in?

Capricor Therapeutics is in the Healthcare sector

What industry is Capricor Therapeutics in?

Capricor Therapeutics is in the Biotechnology industry

What country is Capricor Therapeutics based in?

Capricor Therapeutics is headquartered in United States

When did Capricor Therapeutics go public?

Capricor Therapeutics's initial public offering (IPO) was on February 13, 2007

Is Capricor Therapeutics in the S&P 500?

No, Capricor Therapeutics is not included in the S&P 500 index

Is Capricor Therapeutics in the NASDAQ 100?

No, Capricor Therapeutics is not included in the NASDAQ 100 index

Is Capricor Therapeutics in the Dow Jones?

No, Capricor Therapeutics is not included in the Dow Jones index

When was Capricor Therapeutics's last earnings report?

Capricor Therapeutics's most recent earnings report was on Nov 13, 2024

When does Capricor Therapeutics report earnings?

The next expected earnings date for Capricor Therapeutics is Feb 28, 2025

Should I buy Capricor Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions